Fotivda

Fotivda is an oral medication containing tivozanib, used for targeted therapy in certain cancers. This advanced treatment option is designed to inhibit vascular endothelial growth factor receptors (VEGFR).

Fotivda is primarily used in the treatment of advanced renal cell carcinoma, a type of kidney cancer. It works by targeting and inhibiting the growth of blood vessels that supply nutrients to cancer cells, thereby slowing tumor growth. Patients often wonder, 'What is Fotivda used for?' and the answer lies in its role as a targeted therapy for specific cancer types.

Common effects of Fotivda may include fatigue, high blood pressure, and diarrhea. Some patients might experience changes in taste or appetite. It's important to note that individual responses to the medication can vary, and not everyone will experience these effects.

Fotivda should be handled with care, following the guidance of a healthcare professional. It is essential to monitor blood pressure regularly while using this medication. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their doctor.

Fotivda may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of tivozanib. Always inform your healthcare provider about all medications you are taking.